Jiong-ping Lu

Array ( [id] => 11016686 [patent_doc_number] => 20160213639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS' [patent_app_type] => utility [patent_app_number] => 14/914444 [patent_app_country] => US [patent_app_date] => 2014-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33058 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 50 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10209335 [patent_doc_number] => 20150094325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'Morphinan Derivatives with High Oral Bioavailability' [patent_app_type] => utility [patent_app_number] => 14/506941 [patent_app_country] => US [patent_app_date] => 2014-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5540 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14506941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14360035 [patent_doc_number] => 10301304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Selective inhibitor of phosphatidylinositol 3-kinase-gamma [patent_app_type] => utility [patent_app_number] => 15/024698 [patent_app_country] => US [patent_app_date] => 2014-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11178 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13035269 [patent_doc_number] => 10039747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-07 [patent_title] => Tetrahydrocyclopentapyrrole derivatives and a method for preparing the same [patent_app_type] => utility [patent_app_number] => 14/913696 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17887 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11010951 [patent_doc_number] => 20160207904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'CRYSTALLINE 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE ANSOLVATE SALTS' [patent_app_type] => utility [patent_app_number] => 14/914597 [patent_app_country] => US [patent_app_date] => 2014-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7985 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16925252 [patent_doc_number] => 11046714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => 2,2-difluorodioxolo A [patent_app_type] => utility [patent_app_number] => 14/914843 [patent_app_country] => US [patent_app_date] => 2014-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18459 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18084312 [patent_doc_number] => 11534419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-27 [patent_title] => N-acetyl beta alanine methods of use [patent_app_type] => utility [patent_app_number] => 14/456637 [patent_app_country] => US [patent_app_date] => 2014-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5627 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14456637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10947039 [patent_doc_number] => 20140350060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'Methods of Administering Pirfenidone Therapy' [patent_app_type] => utility [patent_app_number] => 14/454980 [patent_app_country] => US [patent_app_date] => 2014-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13969 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14454980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10821967 [patent_doc_number] => 20160168132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'DI(HETERO)ARYLAMIDES AND SULFONAMIDES, METHODS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/908944 [patent_app_country] => US [patent_app_date] => 2014-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19744 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11059430 [patent_doc_number] => 20160256392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'ABUSE-DETERRENT DOSAGE FORMS' [patent_app_type] => utility [patent_app_number] => 15/033119 [patent_app_country] => US [patent_app_date] => 2014-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10230 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15033119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10925934 [patent_doc_number] => 20140328956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'Use Of Two Botanicals With Complementary Activities For Improvement Of Skin' [patent_app_type] => utility [patent_app_number] => 14/334036 [patent_app_country] => US [patent_app_date] => 2014-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11667 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14334036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13035303 [patent_doc_number] => 10039764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-07 [patent_title] => Treatment and diagnosis of cancer and precancerous conditions using PDE10A inhibitors and methods to measure PDE10A expression [patent_app_type] => utility [patent_app_number] => 14/904632 [patent_app_country] => US [patent_app_date] => 2014-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 26 [patent_no_of_words] => 15773 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9757413 [patent_doc_number] => 20140288114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/298571 [patent_app_country] => US [patent_app_date] => 2014-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 35079 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14298571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10997773 [patent_doc_number] => 20160194718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using Histone H3K27ME3 Biomarkers and Modulators' [patent_app_type] => utility [patent_app_number] => 14/890720 [patent_app_country] => US [patent_app_date] => 2014-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 78667 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9698536 [patent_doc_number] => 20140248221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'COMPOSITIONS FOR ORAL USE AND METHODS FOR TREATING THE ORAL MUCOSA, LIPS, AND PERIORAL REGIONS' [patent_app_type] => utility [patent_app_number] => 14/276323 [patent_app_country] => US [patent_app_date] => 2014-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7798 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14276323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9657739 [patent_doc_number] => 20140228744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'APPLIANCES AND COMPOSITIONS FOR ORAL USE AND METHODS FOR TREATING THE ORAL MUCOSA, LIPS, AND PERIORAL REGIONS' [patent_app_type] => utility [patent_app_number] => 14/254368 [patent_app_country] => US [patent_app_date] => 2014-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8955 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14254368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10248492 [patent_doc_number] => 20150133488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING EPILEPSY' [patent_app_type] => utility [patent_app_number] => 14/251819 [patent_app_country] => US [patent_app_date] => 2014-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14662 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14251819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10926768 [patent_doc_number] => 20140329788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'TESTOSTERONE GEL AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 14/231002 [patent_app_country] => US [patent_app_date] => 2014-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16171 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14231002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9616870 [patent_doc_number] => 20140206728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'DURABLE TREATMENT WITH 4-AMINOPYRIDINE IN PATIENTS WITH DEMYELINATION' [patent_app_type] => utility [patent_app_number] => 14/222535 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14527 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14222535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15696617 [patent_doc_number] => 10604473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-31 [patent_title] => Lipids that increase insulin sensitivity and methods of using the same [patent_app_type] => utility [patent_app_number] => 14/775399 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 63 [patent_no_of_words] => 29625 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775399 [rel_patent_id] =>[rel_patent_doc_number] =>)